Clinical Trial Update: Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0) [Phase 2]

View source ↗

Summary

Phase 2 trial exploring vinorelbine metronomic chemotherapy with hypofractionated radiotherapy followed by PD-1/PD-L1 sequential GM-CSF and IL-2 in advanced ref…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• IL-2 (Interleukin-2)
• PD-1/PD-L1 inhibitors (PD-1/PD-L1 inhibitors)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Second Affiliated Hospital of Soochow University | Conditions: Carcinoma, Non-Small-Cell Lung, Carcinoma Breast | Phase 2 | Status: UNKNOWN